Literature DB >> 31629903

Role of biological agents in treatment of rheumatoid arthritis.

Shing T Law1, Peter C Taylor2.   

Abstract

Advances in understanding of the pathophysiology of rheumatoid arthritis with concurrent advances in protein engineering led to the development of biological disease-modifying antirheumatic drugs which have dramatically revolutionized the treatment of this condition. This review article focuses on the role of biological agents currently employed in the treatment of rheumatoid arthritis, as well as novel biological agents in development. Crown
Copyright © 2019. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biological disease-modifying antirheumatic drugs; Review; Rheumatoid arthritis

Year:  2019        PMID： 31629903     DOI： 10.1016/j.phrs.2019.104497

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN： 1043-6618            Impact factor:   7.658


  14 in total

Review 1.  [Biologicals and small molecules for rheumatoid arthritis].

Authors:  Stephan Blüml
Journal:  Z Rheumatol       Date:  2020-04       Impact factor: 1.372

2.  One-year direct costs of biological therapy in rheumatoid arthritis and its predictive factors: data from the Moroccan RBSMR registry.

Authors:  Safaa Fellous; Hanan Rkain; Samir Ahid; Redouane Abouqal; Latifa Tahiri; Ihsane Hmamouchi; Lahsen Achemlal; Imane El Bouchti; Abdellah El Maghraoui; Imad Ghozlani; Hasna Hassikou; Taoufik Harzy; Linda Ichchou; Ouafa Mkinsi; Radouane Niamane; Rachid Bahiri; Fadoua Allali
Journal:  Rheumatol Int       Date:  2021-01-02       Impact factor: 2.631

3.  Transdermal delivery of inflammatory factors regulated drugs for rheumatoid arthritis.

Authors:  Yanyan Zhang; Zhaoju Gao; Shushu Chao; Wenjuan Lu; Pingping Zhang
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

4.  Biologic therapy for amyloid A amyloidosis secondary to rheumatoid arthritis treated with interleukin 6 therapy: Case report and review of literature.

Authors:  Ju-Yang Jung; Young-Bae Kim; Ji-Won Kim; Chang-Hee Suh; Hyoun-Ah Kim
Journal:  Medicine (Baltimore)       Date:  2021-08-13       Impact factor: 1.817

Review 5.  The immunology of rheumatoid arthritis.

Authors:  Cornelia M Weyand; Jörg J Goronzy
Journal:  Nat Immunol       Date:  2020-11-30       Impact factor: 25.606

6.  A New Peracetylated Oleuropein Derivative Ameliorates Joint Inflammation and Destruction in a Murine Collagen-Induced Arthritis Model via Activation of the Nrf-2/Ho-1 Antioxidant Pathway and Suppression of MAPKs and NF-κB Activation.

Authors:  María Luisa Castejón; Catalina Alarcón-de-la-Lastra; María Ángeles Rosillo; Tatiana Montoya; Jose G Fernández-Bolaños; Alejandro González-Benjumea; Marina Sánchez-Hidalgo
Journal:  Nutrients       Date:  2021-01-22       Impact factor: 5.717

Review 7.  Applicability and implementation of the collagen-induced arthritis mouse model, including protocols (Review).

Authors:  Jing Luan; Zhifang Hu; Jianghong Cheng; Ruisan Zhang; Peng Yang; Huifang Guo; Gang Nan; Na Guo; Xingchun Gou
Journal:  Exp Ther Med       Date:  2021-07-01       Impact factor: 2.447

Review 8.  Recent Findings on Thymoquinone and Its Applications as a Nanocarrier for the Treatment of Cancer and Rheumatoid Arthritis.

Authors:  Ravi Raj Pal; Vasundhara Rajpal; Priya Singh; Shubhini A Saraf
Journal:  Pharmaceutics       Date:  2021-05-22       Impact factor: 6.321

Review 9.  Understanding and Minimising Injection-Site Pain Following Subcutaneous Administration of Biologics: A Narrative Review.

Authors:  Anja St Clair-Jones; Francesca Prignano; Joao Goncalves; Muriel Paul; Philipp Sewerin
Journal:  Rheumatol Ther       Date:  2020-11-18

Review 10.  Unlocking the Value of Anti-TNF Biosimilars: Reducing Disease Burden and Improving Outcomes in Chronic Immune-Mediated Inflammatory Diseases: A Narrative Review.

Authors:  Mourad F Rezk; Burkhard Pieper
Journal:  Adv Ther       Date:  2020-08-01       Impact factor: 3.845
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.